Close-up macro photography of sterile laboratory glassware containing clear active formulation, clean clinical daylight, sharp focus, slate and white tones.
Close-up macro photography of sterile laboratory glassware containing clear active formulation, clean clinical daylight, sharp focus, slate and white tones.
Partner With Us
/ IP-PROTECTED CLINICAL PIPELINE

Targeting primary cicatricial alopecia.

Developing the first approved topical therapy for cicatricial alopecia, backed by rigorous translational medicine and robust intellectual property.

MECHANISM OF ACTION

The FolioScar programme targets primary cicatricial alopecia, a condition with zero approved global therapies. Our novel topical formulation acts on multiple biological pathways to arrest hair follicle destruction.

Targeting the root cause

Clinical Validation

IP-Protected Asset

Partner Alignment

Demonstrated multi-pathway efficacy in human ex vivo hair follicle models, showing significant reduction in inflammatory biomarkers and cellular preservation.

Comprehensive global patent coverage secured for both the topical formulation and specific therapeutic delivery mechanisms, ensuring long-term market exclusivity.

Structured for co-development with institutional funders and clinical research organizations, offering a clear pathway to upcoming clinical trial phases.

Close-up macro photography of a clinical researcher in a sterile environment, focusing on a microscope eyepiece, clean laboratory daylight, sharp focus.
Close-up macro photography of a clinical researcher in a sterile environment, focusing on a microscope eyepiece, clean laboratory daylight, sharp focus.
CLINICAL CREDIBILITY

Validated by peer-reviewed science

Our research is anchored in rigorous clinical validation and led by established PhD investigators. We bridge high-level molecular biology with actionable therapeutic outcomes.

With active IP protection and robust pre-clinical safety profiles, the FolioScar programme represents a highly derisked opportunity for strategic institutional co-development.

Partner With Us

Secure your pipeline stake.

We are actively seeking institutional funders, venture partners, and clinical research organizations to collaborate on upcoming clinical trial phases.